ICU Medical (ICUI)
(Delayed Data from NSDQ)
$179.20 USD
+2.28 (1.29%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $179.39 +0.19 (0.11%) 7:58 PM ET
2-Buy of 5 2
B Value C Growth C Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$179.20 USD
+2.28 (1.29%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $179.39 +0.19 (0.11%) 7:58 PM ET
2-Buy of 5 2
B Value C Growth C Momentum B VGM
Zacks News
ICU Medical's Stock Rises Despite Bivona Tracheostomy Tube Recall
by Zacks Equity Research
ICUI's Smiths Medical recalls Bivona tracheostomy tubes over a defect that may lead to serious health risks, including airway loss and death.
Rockwell Medical, Inc. (RMTI) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
Rockwell Medical (RMTI) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Is SPDR S&P Health Care Equipment ETF (XHE) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for XHE
ICU Medical, Inc. (ICUI) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
ICU Medical (ICUI) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Rockwell Medical, Inc. (RMTI) Hit a 52 Week High, Can the Run Continue?
by Zacks Equity Research
Rockwell Medical (RMTI) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Should You Invest in the SPDR S&P Health Care Equipment ETF (XHE)?
by Zacks Equity Research
Sector ETF report for XHE
ICU Medical, Inc. (ICUI) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
ICU Medical (ICUI) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Is ICU Medical (ICUI) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
ICU Medical (ICUI) Surpasses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
ICU Medical (ICUI) delivered earnings and revenue surprises of 59.18% and 7%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Baxter International (BAX) Beats Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Baxter (BAX) delivered earnings and revenue surprises of 3.03% and 1.80%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Strength Seen in Brainsway (BWAY): Can Its 9.3% Jump Turn into More Strength?
by Zacks Equity Research
Brainsway (BWAY) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Implied Volatility Surging for ICU Medical (ICUI) Stock Options
by Zacks Equity Research
Investors need to pay close attention to ICU Medical (ICUI) stock based on the movements in the options market lately.
ICU Medical (ICUI) Q1 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
ICU Medical (ICUI) delivered earnings and revenue surprises of 14.29% and 2.44%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
BellRing Brands (BRBR) Q2 Earnings and Revenues Top Estimates
by Zacks Equity Research
BellRing Brands (BRBR) delivered earnings and revenue surprises of 32.35% and 5.89%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
ICON (ICLR) Q1 Earnings Surpass Estimates, Margins Expand
by Zacks Equity Research
ICON's (ICLR) first-quarter 2024 performance is driven by its efficient service delivery and strong cost control.
Align Technology (ALGN) Q1 Earnings Top, 2024 Sales View Up
by Zacks Equity Research
Align Technology's (ALGN) first quarter 2024 revenue growth was up across all regions and was driven by strong Clear Aligner volumes, primarily in the Asia Pacific region.
Thermo Fisher (TMO) Q1 Earnings Top Estimates, 2024 View Up
by Zacks Equity Research
Thermo Fisher's (TMO) first-quarter 2024 revenues register year-over-year growth driven by new product launches.
Zacks.com featured highlights include ICU Medical and Ardmore Shipping
by Zacks Equity Research
ICU Medical and Ardmore Shipping are part of the Zacks Screen of the Week article.
ICU Medical (ICUI) Q4 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
ICU Medical (ICUI) delivered earnings and revenue surprises of 33.05% and 4.09%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
2 Stocks in Focus as New Analysts Initiate Coverage
by Shrabana Mukherjee
The recent surge in analyst coverage for stocks such as ICU Medical (ICUI) and Ardmore Shipping (ASC) indicates the potential for significant price appreciation in the near term.
Analysts Estimate ICU Medical (ICUI) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
ICU Medical (ICUI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
BellRing Brands (BRBR) Tops Q1 Earnings and Revenue Estimates
by Zacks Equity Research
BellRing Brands (BRBR) delivered earnings and revenue surprises of 10.26% and 5.51%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Owens & Minor (OMI) Q3 Earnings and Revenues Top Estimates
by Zacks Equity Research
Owens & Minor (OMI) delivered earnings and revenue surprises of 22.22% and 1.22%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?
Do Options Traders Know Something About ICU Medical (ICUI) Stock We Don't?
by Zacks Equity Research
Investors need to pay close attention to ICU Medical (ICUI) stock based on the movements in the options market lately.
ICU Medical's (ICUI) Plum Duo With Safety Shield Gets 510(k) Nod
by Zacks Equity Research
The Plum Duo infusion pump represents the latest addition to ICU Medical's (ICUI) advanced lineup of infusion devices.